Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Fabbrocini

Showing results (31-40 of 624) with videos related to

Pageof 63
Sort By:
Dermatologic Therapy|October 13, 2022
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysisCataldo Patruno, Luca Potestio, Gabriella Fabbrocini, et al.
Journal of Cosmetic Dermatology|September 9, 2022
Hair removal and deodorants in hidradenitis suppurativa: An online survey on patients' habitsWanda Lauro, Gianmarco Capasso, Gabriella Fabbrocini, et al.
Journal of Cosmetic Dermatology|October 28, 2021
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5"Luca Potestio, Elisa Camela, Gabriella Fabbrocini, et al.
Dermatologic Therapy|August 8, 2020
Efficacy and safety of risankizumab in psoriasis patients who failed anti-IL-17, anti-12/23 and/or anti IL-23: Preliminary data of a real-life 16-week retrospective studyMatteo Megna, Gabriella Fabbrocini, Angelo Ruggiero, et al.
International Journal of Trichology|April 10, 2023
Facial Trichoepitheliomas Revealing the Rare Brooke-Spiegler SyndromeF Gaudiello, Luca Costanzo, Gabriella Fabbrocini, et al.
Dermatology and Therapy|April 15, 2021
Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a CaseAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Journal of the American Academy of Dermatology|April 4, 2020
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatmentAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 2, 2018
Contact Urticaria to Ultrasound Gel: A Case ReportSara Cacciapuoti, Anna Masarà, Gabriella Fabbrocini, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|June 11, 2016
UV-selective face cream (Acne RA-1,2) in acne patients: clinical study of its effects on epidermal barrier function, sebum production, tolerability and therapy adherenceGiuseppe Monfrecola, Claudia Capasso, Giuseppe Russo, et al.
Clinical and Experimental Dermatology|January 20, 2023
Comment on 'Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination'Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Pageof 63

Showing results (31-40 of 624) with videos related to

Sort By:
Pageof 63
Dermatologic Therapy|October 13, 2022
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysisCataldo Patruno, Luca Potestio, Gabriella Fabbrocini, et al.
Journal of Cosmetic Dermatology|September 9, 2022
Hair removal and deodorants in hidradenitis suppurativa: An online survey on patients' habitsWanda Lauro, Gianmarco Capasso, Gabriella Fabbrocini, et al.
Journal of Cosmetic Dermatology|October 28, 2021
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5"Luca Potestio, Elisa Camela, Gabriella Fabbrocini, et al.
Dermatologic Therapy|August 8, 2020
Efficacy and safety of risankizumab in psoriasis patients who failed anti-IL-17, anti-12/23 and/or anti IL-23: Preliminary data of a real-life 16-week retrospective studyMatteo Megna, Gabriella Fabbrocini, Angelo Ruggiero, et al.
International Journal of Trichology|April 10, 2023
Facial Trichoepitheliomas Revealing the Rare Brooke-Spiegler SyndromeF Gaudiello, Luca Costanzo, Gabriella Fabbrocini, et al.
Dermatology and Therapy|April 15, 2021
Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a CaseAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Journal of the American Academy of Dermatology|April 4, 2020
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatmentAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 2, 2018
Contact Urticaria to Ultrasound Gel: A Case ReportSara Cacciapuoti, Anna Masarà, Gabriella Fabbrocini, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|June 11, 2016
UV-selective face cream (Acne RA-1,2) in acne patients: clinical study of its effects on epidermal barrier function, sebum production, tolerability and therapy adherenceGiuseppe Monfrecola, Claudia Capasso, Giuseppe Russo, et al.
Clinical and Experimental Dermatology|January 20, 2023
Comment on 'Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination'Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Pageof 63